Sanfer manufactures and sells human and animal health products across more than ten therapeutic fields. The company has operated for over 78 years and has a presence in over 25 countries across Latin America. Over the past two decades Sanfer has completed more than 100 brand acquisitions, acquired eight pharmaceutical companies and launched over 100 new products across Mexico and the region. Led by Chairman and CEO Ricardo Amtmann A., Sanfer provides pharmaceutical solutions to physicians and consumers. The company plans to expand further across Mexico and the broader Latin American region, both organically and through acquisitions. Sanfer recently received a $500M minority investment from CDPQ and existing backer GA will retain a significant minority stake.

Total raised

$500M

Funding rounds

1

Latest round

Equity

Latest activity

Aug 2019